Anti Aging

4

Review clinical trials related to Anti Aging. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Evaluation of the Efficacy and Tolerability of the LED Mask With or Without the Serum Formula on the Signs of Facial Photodamage .

Main objective : To evaluate the anti-aging effectiveness of the LED mask alone on at least one studied anti-aging parameters (including some targeted wrinkles) after 3 months versus baseline Secondary objectives: * Anti-aging clinical score (radiance, skin tone, fine line, ptose, plumpness, ..) * Evaluate the consumer perception (self-evaluation) * Tolerance * Standardized pictures (all light) and pictures analysis * Comparison of effectiveness between the 2 groups (with and without formula

Participants needed: 130
Trial details
Age: 35-60Biological sex: FemaleType: InterventionalSponsor: L'OrealUpdated: Jun 22, 2026Locations: 1
Eligibility criteria

Female subjects aged between 35-60y.o [+12]

Subjects having allergy or sensitivity to LED Light [+18]

Status: Recruiting

iVS-1 Probiotic Intervention Targeting Biological Aging in Midlife Adults

This study is a randomized, double-blind, placebo-controlled clinical trial designed to evaluate the effects of Bifidobacterium adolescentis (iVS-1) supplementation on biological aging markers, metabolic health, and functional health outcomes in midlife adults. The study explores whether modulation of aging-related biological pathways through the gut microbiome may influence health-related outcomes.

Participants needed: 80
Trial details
Age: 40-75Biological sex: AllType: InterventionalSponsor: Synbiotic HealthUpdated: Apr 22, 2026Locations: 1
Eligibility criteria

Aged 40-75 years. [+2]

Chronic disease history (liver, kidney, heart). [+14]

Status: Recruiting

Efficacy and Safety of Resveratrol in Patients With Rheumatoid Arthritis.

The aim of the current study is to evaluate the effects of resveratrol on the clinical outcome(s) of patients with moderate rheumatoid arthritis. Objectives : 1. To investigate the effects of Resveratrol on inflammation and oxidative stress by measuring: * Serum Sirtuin 1(SIRT1) * Serum Myeloperoxidase (MPO) * Serum C-reactive protein (CRP) 2. To investigate the effects of Resveratrol on disease activity by measuring the disease activity (DAS28 score). 3. To investigate the effect of Resveratrol on improving the quality of life using the Health Assessment Questionnaire Disability index (HAQ-DI). 4. To assess any adverse effects related to Resveratrol. Patients: Eligible patients (no=118) will be randomly assigned in a 1:1 ratio to one of two groups: 1. Control group: 59 patients will receive the standard treatment for management of RA for 3 months. 2. Resveratrol group: 59 patients will receive the standard treatment for management of RA in addition to Resveratrol 1 gm daily, (Organix Egypt) (given as one 1000 mg tablets once daily) for 3 months.

Participants needed: 118
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Ain Shams UniversityUpdated: Jul 28, 2025Locations: 1
Eligibility criteria

Adult patients > 18 years old [+3]

Patients receiving biologic DMARDs therapy for RA [+7]

Status: Not yet recruiting

PER-SAF_PDOS (Performance and Safety of Polydioxanone Suture)

This clinical investigation aims to confirm the safety and efficacy of the ID in facial soft tissue reconstruction, specifically for non-incision surgery to tighten and lift the facial skin for a rejuvenated facial appearance.

Participants needed: 50
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: 21 Century Medical Co., Ltd.Updated: Jul 16, 2025
Eligibility criteria

Patients over 18 years old with full legal capacity, male and female; [+2]

Pregnant or breast--feeding women; [+3]